1. Home
  2. BWFG vs NYXH Comparison

BWFG vs NYXH Comparison

Compare BWFG & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWFG
  • NYXH
  • Stock Information
  • Founded
  • BWFG 2002
  • NYXH 2009
  • Country
  • BWFG United States
  • NYXH Belgium
  • Employees
  • BWFG N/A
  • NYXH N/A
  • Industry
  • BWFG Major Banks
  • NYXH Medical/Dental Instruments
  • Sector
  • BWFG Finance
  • NYXH Health Care
  • Exchange
  • BWFG Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • BWFG 223.3M
  • NYXH 261.1M
  • IPO Year
  • BWFG N/A
  • NYXH 2021
  • Fundamental
  • Price
  • BWFG $32.25
  • NYXH $8.22
  • Analyst Decision
  • BWFG Buy
  • NYXH Strong Buy
  • Analyst Count
  • BWFG 1
  • NYXH 5
  • Target Price
  • BWFG $34.00
  • NYXH $17.00
  • AVG Volume (30 Days)
  • BWFG 16.1K
  • NYXH 26.6K
  • Earning Date
  • BWFG 10-28-2024
  • NYXH 11-06-2024
  • Dividend Yield
  • BWFG 2.48%
  • NYXH N/A
  • EPS Growth
  • BWFG N/A
  • NYXH N/A
  • EPS
  • BWFG 1.94
  • NYXH N/A
  • Revenue
  • BWFG $72,009,000.00
  • NYXH $5,668,079.00
  • Revenue This Year
  • BWFG N/A
  • NYXH $37.10
  • Revenue Next Year
  • BWFG $9.07
  • NYXH $418.12
  • P/E Ratio
  • BWFG $16.59
  • NYXH N/A
  • Revenue Growth
  • BWFG N/A
  • NYXH 32.65
  • 52 Week Low
  • BWFG $22.47
  • NYXH $4.00
  • 52 Week High
  • BWFG $33.17
  • NYXH $20.00
  • Technical
  • Relative Strength Index (RSI)
  • BWFG 62.39
  • NYXH 30.23
  • Support Level
  • BWFG $30.73
  • NYXH $8.10
  • Resistance Level
  • BWFG $32.39
  • NYXH $10.01
  • Average True Range (ATR)
  • BWFG 0.78
  • NYXH 0.47
  • MACD
  • BWFG 0.36
  • NYXH -0.19
  • Stochastic Oscillator
  • BWFG 81.85
  • NYXH 6.28

About BWFG Bankwell Financial Group Inc.

Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses, and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: